BioNTech (Germany)

BioNTech (Germany)

BioNTech SE is a German multinational biotechnology company headquartered in Mainz that develops immunotherapies and vaccines, particularly for cancer and infectious diseases. Derived from Wikipedia licensed CC-BY-SA.

Open Access statistics for BioNTech (Germany), Germany, covering academic research published from 2003 to 2024. Read More.


Open Access Percentage

73%


Total
Publications

570


Total Open
Publications

416


Total
Citations

33K


Open Access
Percentage

73%


Total
Publications

570


Total Open
Publications

416


Total
Citations

33K

Wikipedia

Website

download

Breakdown

21% 39% 13% 27%

Publisher Open

21%

Both

39%

Other Platform Open

13%

Closed

27%

Percentage of Open Access over time

0%10%20%30%40%50%60%70%80%90%100%
2003200420052006200720082009201020112012201320142015201620172018201920202021202220232024

Publisher Open

Both

Other Platform Open

Closed

Volume of Open Access over time

0102030405060708090Total Publications
2003200420052006200720082009201020112012201320142015201620172018201920202021202220232024

Open

Closed

Publisher Open

37%OA Journal

OA Journal 37%

127

Hybrid 45%

152

No Guarantees 18%

60

Other Platform Open

Domain 71%

211

Preprint 23%

68

Institution 15%

46

Other Internet 14%

42

Public 9%

26

Other Platform Locations

Name

Platform Type

Publications

PubMed Central
Domain
208
Europe PMC
Domain
73
DOI
Other Internet
50
bioRxiv
Preprint
36
Figshare
Public
25
Research Square
Preprint
13
Semantic Scholar
Public
10
University of Southampton - ePrints Soton
Institution
8
Preprints
Preprint
7
medRxiv
Preprint
6
1 / 6

Data updated 7 April 2025

Share

Share

Share